DRMA

NASDAQ 已收盘

Dermata Therapeutics, Inc.

1.10 USD
-0.10+2.33%
盘后 1.05 -2.33%
2026-08-03
市值
$4.42M
市盈率
EPS
-4.03
股息率
52 周区间
0.95 – 7.14
成交量
46.96K
Beta
0.67
目标价
52W 低 0.9552W 高 7.14
价格走势

公司简介

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.